Kyu Hyung Park
Overview
Explore the profile of Kyu Hyung Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
342
Citations
5333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Song J, Kim M, Joo K, Park S, Woo S, Park K
Retina
. 2024 Aug;
44(9):1486-1494.
PMID: 39167570
Purpose: To investigate the significance of intravitreal anti-vascular endothelial growth factor treatment in patients with neovascular age-related macular degeneration and poor visual acuity. Methods: Retrospective study of patients with neovascular...
12.
Kim D, Kim D, Kwak H, Jang J, Ji Y, Lee S, et al.
Acta Ophthalmol
. 2024 May;
102(7):e1018-e1028.
PMID: 38706195
Purpose: To investigate the long-term efficacy and safety of intravitreal brolucizumab (BRZ) injections in patients with typical neovascular age-related macular degeneration (typical nAMD) and polypoidal choroidal vasculopathy (PCV). Methods: This...
13.
Bae S, Go S, Kim J, Park K, Lee S, Park S
Sci Rep
. 2024 Apr;
14(1):8242.
PMID: 38589440
The aim of this study was to introduce novel vector field analysis for the quantitative measurement of retinal displacement after epiretinal membrane (ERM) removal. We developed a novel framework to...
14.
Bressler N, Kaiser P, Do D, Nguyen Q, Park K, Woo S, et al.
Surv Ophthalmol
. 2024 Mar;
69(4):521-538.
PMID: 38521423
The development of intravitreally injected biologic medicines (biologics) acting against vascular endothelial growth factor (VEGF) substantially improved the clinical outcomes of patients with common VEGF-driven retinal diseases. The relatively high...
15.
Jung Y, Park K, Woo S, Joo K, Kim M
Sci Rep
. 2024 Mar;
14(1):5249.
PMID: 38438557
To compare the efficacy of scleral buckling with adjuvant pneumatic retinopexy (SB with PR) and scleral buckling (SB) alone for primary rhegmatogenous retinal detachment (RRD). This retrospective and comparative study...
16.
Kim D, Lee D, Woo S, Park K, Park S
Sci Rep
. 2024 Mar;
14(1):5251.
PMID: 38438402
Congenital and infantile (CI) cataract is one of the most important and preventable cause of blindness in children, but the incidence has not been studied in Korea. We collected data...
17.
Oh R, Bae K, Yoon C, Park U, Park K, Lee E
Sci Rep
. 2024 Feb;
14(1):4688.
PMID: 38409198
As retinitis pigmentosa (RP) is chronic and progressive, the chronological sequence of microvascular changes is important for understanding its pathophysiology. We aimed to investigate retinal and choroidal microvascular changes according...
18.
Lee H, Bae K, Yoon C, Park U, Park K, Lee E
Sci Rep
. 2024 Feb;
14(1):4690.
PMID: 38409191
This study investigates the impact of glycosylated hemoglobin (HbA1c) on the efficacy of intravitreal dexamethasone (DEX) implants in patients with diabetic macular edema (DME) over a 12-month period. We retrospectively...
19.
Bae S, Bae K, Yoon C, Park U, Park K, Lee E
Retina
. 2024 Feb;
44(6):1006-1014.
PMID: 38346091
Purpose: To investigate the incidence and morphological biomarkers to predict the exudative conversion in eyes with type 1 nonexudative macular neovascularization using swept-source optical coherence tomography angiography. Methods: Macular neovascularizations...
20.
Fujinami-Yokokawa Y, Joo K, Liu X, Tsunoda K, Kondo M, Ahn S, et al.
Invest Ophthalmol Vis Sci
. 2024 Jan;
65(1):41.
PMID: 38265784
Purpose: To characterize the clinical effects of two RP1L1 hotspots in patients with East Asian occult macular dystrophy (OMD). Methods: Fifty-one patients diagnosed with OMD harboring monoallelic pathogenic RP1L1 variants...